Detection of human cytomegalovirus in different histopathological types of glioma in Iraqi patients

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Shamran, Haidar A ^a   Kadhim, Haider S ^a   Hussain, Aws R ^b   Kareem, Abdulameer ^b   Taub, Dennis D ^c   Price, Robert L ^d   Nagarkatti, Mitzi ^d   Nagarkatti, Prakash S ^d   Singh, Udai P ^d  

^a AL NAHRAIN UNIVERSITY   (Iraq)

^b UNIVERSITY OF AL QADISIYAH   (Iraq)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOHISTOCHEMISTRY; IRAQI; MENINGIOMA; MIDDLE AGED; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; VIRUS DETECTION; YOUNG ADULT; BRAIN TUMOR; CYTOMEGALOVIRUS; FEMALE; INFANT; IRAQ; ISOLATION AND PURIFICATION; MALE; PATHOLOGY; PRECANCER; PRESCHOOL CHILD; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GLIOMA; HUMANS; INFANT; IRAQ; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; YOUNG ADULT;

EID: 84924087246     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/642652     Document Type: Article

References (38)

1. G. J. Tortora and B. Derrickson, Principles of Anatomy and Physiology, John Wiley & Sons, New York, NY, USA, 14th edition, 2014.
2. A. P. Kyritsis, M. L. Bondy, J. S. Rao, and C. Sioka, "Inherited predisposition to glioma," Neuro-Oncology, vol. 12, no. 1, pp. 104-113, 2010.
3. G. Prasad and D. A. Haas-Kogan, "Radiation-induced gliomas," Expert Review of Neurotherapeutics, vol. 9, no. 10, pp. 1511-1517, 2009.
4. Iraqi Cancer Registry, 2005.
5. H. Ohgaki and P. Kleihues, "Epidemiology and etiology of gliomas," Acta Neuropathologica, vol. 109, no. 1, pp. 93-108, 2005.
6. L. Soroceanu and C. S. Cobbs, "Is HCMv a tumor promoter?" virus Research, vol. 157, no. 2, pp. 193-203, 2011.
7. L. S. Young, viruses and Human Cancer, Bios Scientific,Oxford, UK, 1998.
8. C. Hawkins and S. Croul, "viruses and human brain tumors: cytomegalovirus enters the fray,"The Journal of Clinical Investigation, vol. 121, no. 10, pp. 3831-3833, 2011.
9. C. Taher, J. de Boniface, A. A. Mohammad et al., "High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes," PLoS ONE, vol. 8, no. 2,Article ID e56795, 2013.
10. F. Tafvizi and Z. T. Fard, "Detection of human cytomegalovirus in patients with colorectal cancer by nested-PCR," Asian Pacific Journal of Cancer Prevention, vol. 15, no. 3, pp. 1453-1457, 2014.
11. L. Geder, R. Lausch, F. O'Neill, and F. Rapp, "Oncogenic transformation of human embryo lung cells by human cytomegalovirus," Science, vol. 192, no. 4244, pp. 1134-1137, 1976.
12. J. Cinatl Jr., J.-U. vogel, H. Rabenau, B. Kornhuber, and H.W. Doerr, "Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells," Intervirology, vol. 39, no. 4, pp. 259-269, 1996.
13. E. S. Amirian,D. Marquez-Do,M. L. Bondy, and M.E. Scheurer, "Antihistamine use and immunoglobulin E levels in glioma risk and prognosis," Cancer Epidemiology, vol. 37, no. 6, pp. 908-912, 2013.
14. S. Sjöström, U. Hjalmars, P. Juto et al., "Human immunoglobulinGlevels of viruses and associated glioma risk," Cancer Causes and Control, vol. 22, no. 9, pp. 1259-1266, 2011.
15. C. S. Cobbs,L. Harkins,M. Samanta et al., "Humancytomegalovirus infection and expression in human malignant glioma," Cancer Research, vol. 62, no. 12, pp. 3347-3350, 2002.
16. N. Baryawno, A. Rahbar, N. Wolmer-Solberg et al., "Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target," The Journal of Clinical Investigation, vol. 121, no. 10, pp. 4043-4055, 2011.
17. D. A. Mitchell,W. Xie, R. Schmittling et al., "Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma," Neuro-Oncology, vol. 10, no. 1, pp. 10-18, 2008.
18. A. Rahbar, G. Stragliotto, A. Orrego et al., "Low levels of human cytomegalovirus infection in glioblastoma multiforme associates with patient survival; a case-control study," Herpesviridae, vol. 3, pp. 3-10, 2012.
19. M. E. Scheurer, M. L. Bondy, K. D. Aldape, T. Albrecht, and R. El-Zein, "Detection of human cytomegalovirus in different histological types of gliomas," Acta Neuropathologica, vol. 116, no. 1, pp. 79-86, 2008.
20. J. Sabatier, E. Uro-Coste, I. Pommepuy et al., "Detection of human cytomegalovirus genome and gene products in central nervous system tumours," British Journal of Cancer, vol. 92, no. 4, pp. 747-750, 2005.
21. S. Poltermann, B. Schlehofer, K. Steindorf, P. Schnitzler, K. Geletneky, and J. R. Schlehofer, "Lack of association of herpesviruses with brain tumors," Journal of Neurovirology, vol. 12, no. 2, pp. 90-99, 2006.
22. S. K. Lau, Y.-Y. Chen,W.-G. Chen et al., "Lack of association of cytomegalovirus with human brain tumors," Modern Pathology, vol. 18, no. 6, pp. 838-843, 2005.
23. X. Wang, S.-M. Huong, M. L. Chiu, N. Raab-Traub, and E.-S. Huang, "Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus," Nature, vol. 424, no.6947, pp.456-461, 2003.
24. T. F. Liu, S. B. Tatter, M. C. Willingham, M. Yang, J. J. Hu, and A. E. Frankel, "Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy," Molecular Cancer Therapeutics, vol. 2, no. 8, pp. 783-787, 2003.
25. T. Kossmann, M. C. Morganti-Kossmann, J. M. Orenstein, W. J. Britt, S. M. Wahl, and P. D. Smith, "Cytomegalovirus production by infected astrocytes correlates with transforming growth factor-β release," The Journal of Infectious Diseases, vol. 187, no. 4, pp. 534-541, 2003.
26. S. Saikali, T. Avril, B. Collet et al., "Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy," Journal of Neuro-Oncology, vol. 81, no. 2, pp. 139-148, 2007.
27. C. S. Cobbs, L. Soroceanu, S. Denham, W. Zhang, and M. H. Kraus, "Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity," Cancer Research, vol. 68, no. 3, pp. 724-730, 2008.
28. R. A. Johnson, X. Wang, X.-L. Ma, S.-M. Huong, and E.- S. Huang, "Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling," Journal of virology, vol. 75, no. 13, pp. 6022-6032, 2001.
29. S. Schmolke, H. F. Kern, P. Drescher, G. Jahn, and B. Plachter, "The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture," Journal of virology, vol. 69, no. 10, pp. 5959-5968, 1995.
30. M. R. Wills, A. J. Carmichael, K. Mynard et al., "The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL," Journal of virology, vol. 70, no. 11, pp. 7569-7579, 1996.
31. E. P. Browne, B. Wing,D. Coleman, and T. Shenk, "Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs," Journal of virology, vol. 75, no. 24, pp. 12319-12330, 2001.
32. D. A. Abate, S. Watanabe, and E. S. Mocarski, "Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response," Journal of virology, vol. 78, no. 20, pp. 10995-11006, 2004.
33. E. R. Kinzler and T. Compton, "Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion," Journal of virology, vol. 79, no. 12, pp. 7827-7837, 2005.
34. M. K. Isaacson and T. Compton, "Human cytomegalovirus glycoprotein B is required for virus entry and cell-to-cell spread but not for virion attachment, assembly, or egress," Journal of virology, vol. 83, no. 8, pp. 3891-3903, 2009.
35. D. Navarro, P. Paz, S. Tugizov, K. Topp, J. La vail, and L. Pereira, "Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection fromcell to cell, and fusion of infected cells," virology, vol. 197, no. 1, pp. 143-158, 1993.
36. F. Jun, L. Minhuan, M. Yadan et al., "Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B," Brazilian Journal of Medical and Biological Research, vol. 45, no. 7, pp. 583-590, 2012.
37. G. Stragliotto, A. Rahbar,N.W. Solberg et al., "Effects of valganciclovir as an add-on therapy in patients with cytomegaloviruspositive glioblastoma: a randomized, double-blind, hypothesisgenerating study," International Journal of Cancer, vol. 133, no. 5, pp. 1204-1213, 2013.
38. N. Baryawno, A. Rahbar, N. Wolmer-Solberg et al., "Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target," Journal of Clinical Investigation, vol. 121, no. 10, pp. 4043-4055, 2011.